Ocean Biomedical (OCEA) Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value Apr 22, 2025 08:03AM
Ocean Biomedical (OCEA) Granted Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 Mar 28, 2025 08:31AM
Ocean Biomedical (OCEA) Announces Breakthrough Findings in EGFR-Mutant Lung Cancer Feb 10, 2025 08:01AM
Ocean Biomedical (OCEA) Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway Jan 29, 2025 08:35AM
Molecure and Ocean Biomedical (OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors Oct 15, 2024 07:36AM